• 1. Aggregation-induced emission of luminol: a novel strategy for fluorescence ratiometric detection of ALP and As(v) with high sensitivity and selectivity?
  Yuan-Jun Tong,Lu-Dan Yu,Lu-Lu Wu,Shu-Ping Cao,Ru-Ping Liang,Li Zhang,Xing-Hua Xia,Jian-Ding Qiu Chem. Commun., 2018,54, 7487-7490
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 4. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 5. An ionic liquid-mesoporous silica blend as a novel adsorbent for the adsorption and recovery of palladium ions, and its applications in continuous flow study and as an industrial catalyst?
  Shivani Sharma,Chia-Ming Wu,Ranjit T. Koodali,N. Rajesh RSC Adv., 2016,6, 26668-26678

Chemical Profile of (S)-1-(4-Bromophenyl)propan-1-amine (CAS No. 1108684-03-2)

The compound (S)-1-(4-Bromophenyl)propan-1-amine, identified by its CAS number 1108684-03-2, is a significant molecule in the field of pharmaceutical chemistry and bioorganic synthesis. This enantiomerically pure amine derivative features a chiral center at the propan-1-amine moiety, making it a valuable intermediate in the development of various pharmacologically active agents. The presence of a brominated aromatic ring further enhances its utility in medicinal chemistry due to the versatile reactivity of the bromine substituent.

In recent years, the demand for enantiomerically pure compounds has surged, driven by the need for more selective and effective drugs. The stereochemistry of (S)-1-(4-Bromophenyl)propan-1-amine plays a crucial role in determining its biological activity. For instance, many pharmaceuticals exhibit pronounced enantioselectivity, where one enantiomer is therapeutically active while the other may be inactive or even harmful. This compound's well-defined stereochemical configuration makes it an attractive building block for asymmetric synthesis.

The bromophenyl group in (S)-1-(4-Bromophenyl)propan-1-amine is particularly noteworthy for its synthetic utility. Bromine atoms are excellent handles for further functionalization via cross-coupling reactions such as Suzuki-Miyaura, Heck, and Buchwald-Hartwig couplings. These reactions are fundamental in constructing complex molecular architectures, enabling the synthesis of heterocyclic compounds and biaryl structures that are prevalent in modern drug candidates. The ability to introduce diverse functional groups at the aromatic ring and the chiral amine moiety provides chemists with a high degree of flexibility in designing novel molecules.

Current research in medicinal chemistry increasingly focuses on developing small-molecule inhibitors targeting protein-protein interactions (PPIs). Compounds like (S)-1-(4-Bromophenyl)propan-1-amine serve as key scaffolds in this endeavor. The chiral amine can interact with specific amino acid residues in protein binding pockets, while the bromophenyl group can engage in π-stacking or hydrophobic interactions. Such interactions are critical for achieving high affinity and selectivity. Recent studies have demonstrated that derivatives of this compound exhibit promising activity against enzymes involved in inflammatory pathways, making them potential candidates for therapeutic intervention.

Another emerging area where (S)-1-(4-Bromophenyl)propan-1-amine finds application is in the development of chemokine receptor antagonists. Chemokines are small proteins that play a pivotal role in immune cell migration and inflammation. By designing molecules that bind to chemokine receptors, researchers aim to modulate immune responses for treating autoimmune diseases and infections. The structural features of this compound allow it to mimic natural ligands or interfere with receptor signaling, offering a strategic approach to drug design.

The synthesis of enantiomerically pure amines remains a challenge in organic chemistry, but advances in catalytic asymmetric methods have made it more feasible. Techniques such as asymmetric hydrogenation and chiral auxiliaries have enabled efficient access to compounds like (S)-1-(4-Bromophenyl)propan-1-amine. These methods not only improve yield and purity but also reduce environmental impact by minimizing waste generation. The growing emphasis on green chemistry principles aligns well with these advancements, ensuring that future syntheses are both efficient and sustainable.

In conclusion, (S)-1-(4-Bromophenyl)propan-1-amine (CAS No. 1108684-03-2) is a versatile and highly valuable compound in pharmaceutical research. Its unique structural features make it an excellent candidate for further derivatization and application in drug discovery programs targeting various diseases. As synthetic methodologies continue to evolve, the potential applications of this compound are expected to expand, contributing significantly to the development of next-generation therapeutics.

• 90642-45-8(1-(3-Bromophenyl)propan-1-amine)
• 1391577-97-1((S)-1-(4-Bromophenyl)propan-1-amine hydrochloride)
• 1391414-30-4((R)-1-(4-Bromophenyl)pentan-1-amine hydrochloride)
• 856758-61-7((1R)-1-(4-Bromophenyl)propan-1-amine)
• 760171-71-9((S)-1-(3-Bromophenyl)propan-1-amine)
• 856562-96-4((R)-1-(4-Bromophenyl)propan-1-amine hydrochloride)
• 90485-18-0(1-(4-Bromophenyl)propan-1-amine Hydrochloride)
• 146781-56-8(4-Bromo-α-propyl-benzenemethanamine)
• 623143-34-0((S)-1-(3-Bromophenyl)propan-1-amine hydrochloride)
• 74877-09-1(1-(4-Bromophenyl)propan-1-amine)